248 related articles for article (PubMed ID: 18616417)
21. Accelerated atherosclerosis, immune response and autoimmune rheumatic diseases.
Jara LJ; Medina G; Vera-Lastra O; Amigo MC
Autoimmun Rev; 2006 Mar; 5(3):195-201. PubMed ID: 16483919
[TBL] [Abstract][Full Text] [Related]
22. Systemic lupus erythematosus and other autoimmune rheumatic diseases: challenges to treatment.
Murphy G; Lisnevskaia L; Isenberg D
Lancet; 2013 Aug; 382(9894):809-18. PubMed ID: 23972423
[TBL] [Abstract][Full Text] [Related]
23. Atherosclerosis in rheumatoid arthritis and systemic lupus erythematosus.
Haque S; Mirjafari H; Bruce IN
Curr Opin Lipidol; 2008 Aug; 19(4):338-43. PubMed ID: 18607179
[TBL] [Abstract][Full Text] [Related]
24. Altered lipoprotein metabolism in chronic inflammatory states: proinflammatory high-density lipoprotein and accelerated atherosclerosis in systemic lupus erythematosus and rheumatoid arthritis.
Hahn BH; Grossman J; Ansell BJ; Skaggs BJ; McMahon M
Arthritis Res Ther; 2008; 10(4):213. PubMed ID: 18828865
[TBL] [Abstract][Full Text] [Related]
25. The Pharmacological Mechanisms and Therapeutic Activities of Hydroxychloroquine in Rheumatic and Related Diseases.
Hu C; Lu L; Wan JP; Wen C
Curr Med Chem; 2017; 24(20):2241-2249. PubMed ID: 28302011
[TBL] [Abstract][Full Text] [Related]
26. Efficacy and safety of statins in the prevention of atherosclerosis in patients with systemic lupus erythematosus--a meta-analysis of randomized controlled trials.
Ye Y; Zhao X; Xie H; Tian Z; Zhang S
Int J Cardiol; 2013 Jul; 167(1):301-3. PubMed ID: 23084817
[No Abstract] [Full Text] [Related]
27. At the Bedside: Neutrophil extracellular traps (NETs) as targets for biomarkers and therapies in autoimmune diseases.
Barnado A; Crofford LJ; Oates JC
J Leukoc Biol; 2016 Feb; 99(2):265-78. PubMed ID: 26658004
[TBL] [Abstract][Full Text] [Related]
28. The endothelium: an interface between autoimmunity and atherosclerosis in systemic lupus erythematosus?
Narshi CB; Giles IP; Rahman A
Lupus; 2011 Jan; 20(1):5-13. PubMed ID: 21138982
[TBL] [Abstract][Full Text] [Related]
29. Tobacco smoking and autoimmune rheumatic diseases.
Harel-Meir M; Sherer Y; Shoenfeld Y
Nat Clin Pract Rheumatol; 2007 Dec; 3(12):707-15. PubMed ID: 18037930
[TBL] [Abstract][Full Text] [Related]
30. Cardio-Rheumatology: Cardiovascular Complications in Systemic Autoimmune Rheumatic Diseases / Is Inflammation the Common Link and Target?
Manolis AS; Tzioufas AG
Curr Vasc Pharmacol; 2020; 18(5):425-430. PubMed ID: 32410564
[TBL] [Abstract][Full Text] [Related]
31. Statins and autoimmune diseases.
Riboldi P; Gerosa M; Meroni PL
Lupus; 2005; 14(9):765-8. PubMed ID: 16218484
[TBL] [Abstract][Full Text] [Related]
32. Pitavastatin: novel effects on lipid parameters.
Chapman MJ
Atheroscler Suppl; 2011 Nov; 12(3):277-84. PubMed ID: 22152282
[TBL] [Abstract][Full Text] [Related]
33. Infections in the immunocompromised rheumatologic patient.
Greenberg SB
Crit Care Clin; 2002 Oct; 18(4):931-56. PubMed ID: 12418448
[TBL] [Abstract][Full Text] [Related]
34. Statins Therapy for Connective Tissue Diseases: New Therapeutic Opportunities.
Kotyla PJ; Kucharz EJ
Endocr Metab Immune Disord Drug Targets; 2018 Feb; 18(2):135-147. PubMed ID: 29149821
[TBL] [Abstract][Full Text] [Related]
35. Anti-inflammatory and immunomodulating properties of statins. An additional tool for the therapeutic approach of systemic autoimmune diseases?
Meroni PL; Luzzana C; Ventura D
Clin Rev Allergy Immunol; 2002 Dec; 23(3):263-77. PubMed ID: 12402412
[TBL] [Abstract][Full Text] [Related]
36. Statins and cardiovascular risk in rheumatic diseases.
Marasini B; Massarotti M
Int J Immunopathol Pharmacol; 2012; 25(1):25-30. PubMed ID: 22507314
[TBL] [Abstract][Full Text] [Related]
37. Hematological Manifestations among Patients with Rheumatic Diseases.
Klein A; Molad Y
Acta Haematol; 2021; 144(4):403-412. PubMed ID: 33221805
[TBL] [Abstract][Full Text] [Related]
38. Cardiovascular disease in autoimmune rheumatic diseases.
Hollan I; Meroni PL; Ahearn JM; Cohen Tervaert JW; Curran S; Goodyear CS; Hestad KA; Kahaleh B; Riggio M; Shields K; Wasko MC
Autoimmun Rev; 2013 Aug; 12(10):1004-15. PubMed ID: 23541482
[TBL] [Abstract][Full Text] [Related]
39. Successful therapy with danazol in refractory autoimmune thrombocytopenia associated with rheumatic diseases.
Blanco R; Martinez-Taboada VM; Rodriguez-Valverde V; Sanchez-Andrade A; González-Gay MA
Br J Rheumatol; 1997 Oct; 36(10):1095-9. PubMed ID: 9374927
[TBL] [Abstract][Full Text] [Related]
40. Apolipoprotein A-I mimetic peptides.
Van Lenten BJ; Wagner AC; Anantharamaiah GM; Navab M; Reddy ST; Buga GM; Fogelman AM
Curr Atheroscler Rep; 2009 Jan; 11(1):52-7. PubMed ID: 19080728
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
